Taurodeoxycholic acid-YAP1 upregulates OTX1 in promoting gallbladder cancer malignancy through IFITM3-dependent AKT activation

Oncogene. 2023 May;42(18):1466-1477. doi: 10.1038/s41388-023-02660-3. Epub 2023 Mar 16.

Abstract

Orthodenticle homeobox (OTX1) is reported to be involved in numerous cancers, but the expression level and molecular function of OTX1 in gallbladder cancer (GBC) remain unknown. Here, we found the elevated level of OTX1 associated with poor prognosis in human gallbladder cancer. In vitro and in vivo studies of human gallbladder cancer cell lines demonstrated that overexpression of OTX1 promoted cell proliferation, whereas the downregulation inhibited it. Additionally, we found a tight correlation between the serum level of taurodeoxycholic acid (TDCA) and OTX1 expression. TDCA-induced activation of YAP1 by phosphorylation inhibition contributed to the transcriptional activation of OTX1. Mechanistically, we identified that OTX1 activated AKT signaling pathway by transactivating the expression of IFITM3 and thus promoted the proliferation of GBC cells. Taken together, our results showed that TDCA-YAP1-dependent expression of OTX1 regulated IFITM3 and affected GBC proliferation via the AKT signaling pathway. Our experiments also suggested that OTX1 is a novel therapeutic target for GBC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Cell Proliferation / physiology
  • Gallbladder Neoplasms* / metabolism
  • Humans
  • Membrane Proteins / metabolism
  • Otx Transcription Factors / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism
  • RNA-Binding Proteins / metabolism
  • Signal Transduction
  • Taurodeoxycholic Acid / pharmacology

Substances

  • IFITM3 protein, human
  • Membrane Proteins
  • Otx Transcription Factors
  • OTX1 protein, human
  • Proto-Oncogene Proteins c-akt
  • RNA-Binding Proteins
  • Taurodeoxycholic Acid